Category: Research

Research at the University of North Carolina at Chapel Hill continues to grow, bringing in more than $1.2 billion in funding awards during the 2022 fiscal year. This is the third year in a row that research awards have topped $1 billion, facilitating research projects and experiments for external sponsors like...

The lab of Ian Shih, PhD, received the top prize from the journal NeuroImage for brain research featuring fMRI and fast-scan cyclic voltammetry. First author was Lindsay Walton, PhD.

UNC School of Medicine researchers led by Ian Shih, PhD, used fMRI and a genetic mouse model to study the effects of a neurotransmitter on brain network functional connectivity, a dynamic process crucial for human health and behavior.

James F. Howard, Jr, MD, in the UNC Department of Neurology is the lead primary investigator in the CHAMPION-MG trial for Ultomiris (ravulizumab-cwvz) as a treatment for adults with generalised myasthenia gravis who are anti-acetylcholine receptor antibody-positive, which represents 80% of people living with the disease.

James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the ADAPT+ trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.

NC TraCS awarded funding for a $5K-$50K grant application submitted by Rebecca Traub, MD and Xiaoyan Li, MD, PhD.

James F. Howard Jr., MD, professor in the UNC Department of Neurology, was lead investigator in UCB's RAISE trial to evaluate zilucoplan as a treatment for generalized myasthenia gravis in adults.

Dr. Timothy Gershon is co-corresponding author of new research that appeared in Sciences Advances, January 26, 2022.

James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the phase 3 trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.

The American Academy of Neurology awarded Monica M. Diaz, MD, MS, a Clinical Research Training Scholarship in support of her research on the detection of neurodegeneration in older, cognitively impaired people with HIV.